LBTD — Lotus Bio-Technology Development Income Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeMicro Cap

Annual income statement for Lotus Bio-Technology Development, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2013 March 31st	R2014 March 31st	2015 March 31st	R2016 March 31st	2017 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K/A
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Total Revenue	0	0	0	0	0
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	0.062	0.016	0.019	0.019	0.02
Operating Profit	-0.062	-0.016	-0.019	-0.019	-0.02
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-0.062	-0.016	-0.019	-0.019	-0.02
Provision for Income Taxes
Net Income After Taxes	-0.062	-0.016	-0.019	-0.019	-0.02
Net Income Before Extraordinary Items
Net Income	-0.062	-0.016	-0.019	-0.019	-0.02
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.062	-0.016	-0.019	-0.019	-0.02
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0	-0	-0	-0	-0
Dividends per Share